| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.0B | $14.3B | $13.3B | $11.9B | $11.9B | $2.9B | $2.8B | $2.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $1.3B | $1.0B | $1.2B | $0.9B | $1.2B | $0.4B | $0.3B | $-0.1B |
| EPS (Basic) | $4.71 | $3.53 | $4.44 | $3.29 | $4.42 | $1.42 | $1.00 | $-0.31 |
| EPS (Diluted) | $4.69 | $3.52 | $4.43 | $3.28 | $4.41 | $1.42 | $1.00 | $-0.31 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $69.4B | $66.5B | $64.7B | $60.9B | $66.6B | $64.0B | $60.6B | $57.2B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.4B | $0.5B | $0.3B | $0.5B | $0.5B | $0.4B | $0.2B | $0.3B |
| Total Liabilities | $57.8B | $56.0B | $54.8B | $52.1B | $53.8B | $51.3B | $48.4B | $45.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $11.6B | $10.5B | $9.9B | $8.8B | $12.8B | $12.7B | $12.2B | $11.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $2.5B | $2.6B | $2.3B | $2.5B | $2.0B | $1.8B | $1.1B | $1.2B |
| Investing Cash Flow | $-1.4B | $-1.3B | $-1.8B | $-1.5B | $-1.2B | $-0.7B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.1B |
| Financing Cash Flow | $-1.1B | $-1.1B | $-0.6B | $-1.0B | $-0.6B | $-0.9B | $-1.0B | $-1.1B |